EARLY DIABETIC NEPHROPATHY - EMERGING TREATMENT OPTIONS

被引:0
|
作者
CAVELLA, MJ
GOSSAIN, VV
ROVNER, DR
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic nephropathy affects approximately 35% of patients with insulin-dependent diabetes mellitus and about 5% to 100% of patients with on-insulin-dependent diabetes mellits. Diabetic kidney disease can be detected early by special methods that measure microalbuminuria in the range of 15 to 140 mu g/min or 0.02 to 0.20 g/d. Specific strategies have been proved beneficial in patients with this early diabetic kidney disease, also called incipient nephropathy. ''Protein restriction, tight control of blood sugar and blood pressure, and specific therapy with angiotensin-converting enzyme inhibitors have been shown independently to reduce microalbuminuria and preserve renal function in these patients. We review the pathogenesis of diabetic kidney disease and discuss the effects of these treatment strategies on the renal, cardiovascular, metabolic, and other abnormalities found in early (incipient) and overt diabetic nephropathy.
引用
收藏
页码:625 / 630
页数:6
相关论文
共 50 条
  • [1] Treatment options in diabetic nephropathy
    Morgenroth, R.
    Mertens, Peter R.
    Herzog, C.
    Scurt, Florian G.
    [J]. DIABETOLOGIE, 2023, 19 (03): : 271 - 280
  • [2] Emerging drugs for the treatment of diabetic nephropathy
    Kim, Yoon Kook
    Ning, Xinyuan
    Munir, Kashif M.
    Davis, Stephen N.
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2022, 27 (04) : 417 - 430
  • [3] Emerging therapeutics for the treatment of diabetic nephropathy
    Brenneman, Jehrod
    Hill, Jon
    Pullen, Steve
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (18) : 4394 - 4402
  • [4] Standard and Emerging Treatment Options for Diabetic Neuropathy
    Tentolouris, Nicholas
    Alexiadou, Kleopatra
    Makrilakis, Konstantinos
    Liatis, Stavros
    Jude, Edward
    Boulton, Andrew J.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (22) : 3689 - 3704
  • [5] A Narrative Review of New Treatment Options for Diabetic Nephropathy
    Pillai, Aadhira
    Fulmali, Darshna
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [6] PHARMACOLOGICAL TREATMENT OF EARLY DIABETIC NEPHROPATHY
    JERUMS, G
    ALLEN, TJ
    HENDRICH, EC
    MCNALLY, PG
    [J]. NEFROLOGIA, 1994, 14 (02): : 127 - &
  • [7] Emerging role of thiamine therapy for prevention and treatment of early-stage diabetic nephropathy
    Rabbani, N.
    Thornalley, P. J.
    [J]. DIABETES OBESITY & METABOLISM, 2011, 13 (07): : 577 - 583
  • [8] Diabetic Nephropathy New Treatment options for a major clinical Problem
    Wolf, G.
    Haller, H.
    [J]. NEPHROLOGE, 2020, 15 (03): : 135 - 135
  • [9] A Narrative Review of Signaling Pathway and Treatment Options for Diabetic Nephropathy
    Bhupesh, Semwal
    Chauhan, Neha
    Jyoti, Verma
    Ankit, Kumar
    Sonia, Singh
    Bhupendra, Singh
    [J]. CURRENT MOLECULAR MEDICINE, 2024,
  • [10] Emerging treatment options for early mycosis fungoides
    Fernandez-Guarino, Montserrat
    [J]. CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2013, 6 : 61 - 69